Defining polycystic ovary syndrome

BMJ (Online)

Volumn 338, Issue 7692, 2009, Pages 426-

  Balen, Adam ^a   Homburg, Roy ^b   Franks, Stephen ^c  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; INSULIN; SEX HORMONE; TESTOSTERONE;

ACNE; ALOPECIA; AMENORRHEA; AUSTRALIA; EDITORIAL; EUROPE; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; MENSTRUAL CYCLE; OLIGOMENORRHEA; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STEROIDOGENESIS; ULTRASOUND; UNITED STATES;

CONSENSUS; FEMALE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME;

EID: 61849159706     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a2968     Document Type: Editorial

References (12)

1. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-88.
2. Stein I, Leventhal M. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-5.
3. Zawadski, JK Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A; Givens JR; Haseltine F, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific, 1992:377-84.
4. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
5. Balen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505-14.
6. Barth J, Yasmin E, Balen AH. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin Endocrinol 2007;67:811-5.
7. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxford) 1999;51:779-86.
8. Willis D, Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 1995;80:3788-90.
9. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implication for pathogenesis. Endocr Rev 1997;18:774-800.
10. Wijeyaratne CN, Balen AH, Barth J, Belchetz PE. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol 2002;57:343-50.
11. Franks S. Diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 2006;91:786-9.
12. Jones GL, Hall JM, Balen AH, Ledger W. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update 2008;14:15-25.